KALV (KalVista Pharmaceuticals) Pangali Forward P/E

Logo korporat perusahaan KalVista Pharmaceuticals Inc (KALV)

Anticipation of late-stage clinical trial results for an oral treatment to manage angioedema attacks serves as the primary growth trigger for KalVista Pharmaceuticals (KALV). The forward P/E ratio of KalVista Pharmaceuticals (KALV) on the GURU.Markets chart, where the metric value is 33.90, confirms the stability of a business creating convenient, high-margin tablets. This approach establishes a unique therapeutic ecosystem, transforming the developments of KalVista Pharmaceuticals (KALV) into an indispensable standard of care for rare pathologies.

Prakiraan rega marang bathi: KalVista Pharmaceuticals, Inc. (KALV) kanggo 04.07.2022 - 21.06.2026

Rincian analitis perusahaan KalVista Pharmaceuticals

Ringkesan analitik perusahaan:kalvista.com
Sampel barang KalVista Pharmaceuticals

The fate of KalVista Pharmaceuticals (KALV) depends on the clinical trial results of its drug for hereditary angioedema. The company's forward P/E ratio compares the current share price with projected net income for future periods. This indicator measures market expectations, demonstrating the extent of the premium paid for future earnings. This chart reflects investor reaction to regulatory risks and capital requirements, allowing for an assessment of the fairness of the market capitalization.

Pesaing KalVista Pharmaceuticals (KALV)

Prakiraan rega marang bathi ARGX (Argenx)|BNTX (BioNTech Group) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E ABVX (Abivax SA)|Kapitalisasi marang proyeksi bathi admabiologics.com (ADMA)|PTGX - Rega marang bathi mangsa ngarep|Immunovant Inc (IMVT) - Prakiraan rega marang bathi|Kiniksa Corp (KNSA) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Grifols, S.A.|Prakiraan rega marang bathi ADPT|Pangali Forward P/E celldex.com|Rega marang bathi mangsa ngarep Aurinia Pharma (AUPH)|BioCryst Pharmaceuticals - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E VERA (veratx.com)|Dianthus Pharma (DNTH) - Rasio prakiraan rega marang bathi|PHVS - Rega marang bathi mangsa ngarep|ABCL - Pangali Forward P/E|Tourmaline (TRML) - Rega marang bathi mangsa ngarep|Precigen - Pangali mangsa ngarep rega marang bathi|PHAR (Pharming Group NV) - Pangali Forward P/E|Pangali Forward P/E Nektar Therapeutics|Rega marang bathi mangsa ngarep Upstream Bio Inc (UPB)|Pangali Forward P/E zenasbio.com (ZBIO)|Rega marang bathi mangsa ngarep Immunome Corp IMNM|Pangali Forward P/E Gossamer Bio Inc GOSS|SEPN - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Pieris Pharmaceuticals PVLA|SVRA (Savara Inc.) - Prakiraan rega marang bathi|Rasio rega marang bathi sing dikarepake RIGL (Rigel Pharmaceuticals)|ANAB (AnaptysBio) - Pangali Forward P/E|ATXS (Astria Therapeutics, Inc.) - Rasio kapitalisasi marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep engene.com (ENGN)|RAPT (RAPT Therapeutics, Inc.) - Pangali mangsa ngarep rega marang bathi|Aerovate Therapeutics - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi ACRS|Kyverna Therapeutics, Inc - Pangali Forward P/E|Rasio rega marang bathi sing dikarepake TLSA|CABA: Pangali Forward P/E|Prakiraan rega marang bathi Ventyx Bio|Rega marang bathi mangsa ngarep Theratechnologies, Inc.|Rasio prakiraan rega marang bathi Avalo Therapeutics AVTX|Pangali Forward P/E ELDN|AGEN (Agenus, Inc.) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Climb Bio, Inc. CLYM|Zura Bio Limited (ZURA) - Rasio prakiraan rega marang bathi|ATYR: Prakiraan rega marang bathi|adagene.com (ADAG) - Prakiraan rega marang bathi|Ikena Oncology (IMA) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Shattuck Labs, Inc.|Rega marang bathi mangsa ngarep equilliumbio.com|Prakiraan rega marang bathi connectbiopharm.com (CNTB)|Pangali Forward P/E IMUX|Kapitalisasi marang proyeksi bathi Atara Bio|Rega marang bathi mangsa ngarep InflaRx N.V. IFRX|X4 Pharmaceuticals - Rega marang bathi mangsa ngarep|ACET: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CELU (celularity.com)|INMB: Pangali Forward P/E|BRNS: Rasio kapitalisasi marang bathi mangsa ngarep|KZR (Kezar Life Sciences, Inc.) - Pangali Forward P/E|SAB Biotherapeutics Inc. (SABS) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E AKTX|Rega marang bathi mangsa ngarep ENLV (Enlivex Therapeutics Ltd)|Rega marang bathi mangsa ngarep Q32 Bio Inc. QTTB|GOVX - Prakiraan rega marang bathi|EDSA - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi iBio|CARM: Pangali Forward P/E|Rasio rega marang bathi sing dikarepake XTLB (XTL Biopharmaceuticals, Ltd.)|Rega marang bathi mangsa ngarep boltbio.com|Pangali Forward P/E HCW Biologics|Pangali Forward P/E APVO|AIM - Rasio prakiraan rega marang bathi|Pangali Forward P/E ADTX (Aditxt Inc.)|Kapitalisasi marang proyeksi bathi GRI Bio, Inc. (GRI)|XRTX - Rega marang bathi mangsa ngarep|reshapelifesciences.com (HIND) - Prakiraan rega marang bathi|REVB: Pangali Forward P/E|Indaptus Therapeutics, Inc. - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Scinai|Rasio prakiraan rega marang bathi CalciMedica, Inc. CALI|Rega marang bathi mangsa ngarep Affimed NV (AFMD)|Pangali Forward P/E Allakos Inc (ALLK)|Rega marang bathi mangsa ngarep hookipapharma.com HOOK|Pangali Forward P/E IGM Biosciences, Inc. IGMS|iTeos Pharma - Pangali Forward P/E|OCEA - Pangali Forward P/E|TCBP: Pangali Forward P/E|Third Harmonic Bio - Pangali mangsa ngarep rega marang bathi